Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Many patients under Klinics care in Willimantic begin to recognize changes in appetite within just one week and notice measurable weight loss by the fourth week
RESEARCH AREAS Pan-ERR (ERR//) receptor binding and agonist activation mechanisms Transcriptional regulation of mitochondrial biogenesis pathways in cell models Modulation of oxidative phosphorylation and fatty-acid oxidation gene sets PGC-1/ERR signaling-axis interactions in cultured myocyte systems WHAT RESEARCHERS LOOK AT Receptor-binding affinity and isoform selectivity assays Reporter-gene transcriptional activation readouts in transfected cell lines qPCR/RNA-seq profiling of ERR target-gene expression in vitro Compound stability, solubility, and purity verification by HPLC and mass spectrometry QUICK SPECS Form: Capsule not for ingestion Net per capsule: 100mcg Count: 60 capsules per bottle Purity: 98% (HPLC) Identity: Confirmed by mass spectrometry Storage: Cool, dry conditions away from light IDENTITY BASICS Type: Synthetic small-molecule ERR agonist (non-peptide) Molecular Formula: CHClNO Molecular Weight: ~426.9 g/mol CAS: 2756409-79-1 SELECTED RESEARCH PubChem: SLU-PP-332 compound record PubMed: ERR agonist SLU-PP-332 studies PubMed: ERR and mitochondrial biogenesis PubMed: ERR oxidative metabolism regulation DISCLAIMER For laboratory research use only
Other findings indicate a higher predisposition to adverse effects plays a role in the drop off too
Patients may no longer benefit from preventive medications and use certain medications for symptomatic management
US$ 23.27
US$ 20.76
US$ 25.21
US$ 28.80
US$ 26.53
US$ 27.35
US$ 29.77
US$ 27.08
US$ 29.72
